Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 11Breast 6Thoracic 3Dermatologic 2Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1

Conditions

Melanoma 791Carcinoma, Non-Small-Cell Lung 171Skin Neoplasms 154Neoplasms 107Neoplasm Metastasis 100Colorectal Neoplasms 96Carcinoma, Renal Cell 96Uveal Melanoma 92Breast Neoplasms 88Squamous Cell Carcinoma of Head and Neck 85Carcinoma, Basal Cell 85Lung Neoplasms 80Ovarian Neoplasms 79Lymphoma, T-Cell, Cutaneous 67Carcinoma, Merkel Cell 67Sarcoma 66Pancreatic Neoplasms 59Stomach Neoplasms 58Head and Neck Neoplasms 55Carcinoma, Hepatocellular 54Uterine Cervical Neoplasms 53Urinary Bladder Neoplasms 50Triple Negative Breast Neoplasms 44Esophageal Neoplasms 44Prostatic Neoplasms 43Endometrial Neoplasms 42Carcinoma, Squamous Cell 39Brain Neoplasms 39Carcinoma, Transitional Cell 37Lymphoma 34

Interventions

fludarabine phosphate 1fludarabine 1aldesleukin 1Spinal Puncture 1Specimen Handling 1Nivolumab 1Mesna 1Magnetic Resonance Spectroscopy 1Interleukin-2 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Meningeal Neoplasms × Dermatologic × 1 year × Clear all
NCT03025256 2026-05-05

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase 1 Recruiting
75 enrolled
DermatologicThoracic

Uveal Melanoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Meningeal Neoplasms, Nevus

NCT00338377 2026-03-20

Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
1,230 enrolled
Dermatologic

Melanoma, Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡